epigallocatechin gallate has been researched along with su 11248 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Cheng, K; Dong, H; Gao, F; Ge, J; He, JP; Hou, JM; Li, HZ; Li, LH; Lin, HJ; Liu, JY; Peng, XC; Qiu, M; Su, JM; Tan, BX; Wei, M; Wu, Y; Yang, L; Zhao, Y; Zhao, YL | 1 |
Ding, J; Du, Y; Liu, JY; Tang, J; Zhou, Y | 1 |
Eisenstein, M | 1 |
3 other study(ies) available for epigallocatechin gallate and su 11248
Article | Year |
---|---|
Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability.
Topics: Animals; Biological Availability; Catechin; Chemical Precipitation; Herb-Drug Interactions; Humans; Indoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Plant Extracts; Pyrroles; Rats; Rats, Sprague-Dawley; Sunitinib; Tea | 2011 |
The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Breast Neoplasms; Catechin; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Indoles; Insulin Receptor Substrate Proteins; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Prognosis; Pyrroles; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sunitinib; Tea; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Tea's value as a cancer therapy is steeped in uncertainty.
Topics: Animals; Biological Products; Case-Control Studies; Catechin; Cell Line, Tumor; China; Cohort Studies; Dietary Supplements; Disease Models, Animal; Female; Humans; Incidence; Japan; Life Style; Male; Metabolic Syndrome; Mice; Neoplasms; Plant Extracts; Prostatic Neoplasms; Sex Factors; Smoking; Sunitinib; Tea; Uncertainty | 2019 |